Funder: Pfizer Inc.
Due Dates: May 4, 2026 (Submission Deadline, full application — due by 23:59 EST)
Funding Amounts: Up to $120,000 USD per project; up to $180,000 USD if third-party lab services required; maximum project duration 3 years.
Summary: Supports research on pneumococcal disease serotype distribution and antimicrobial resistance in pediatric and adult populations in Turkey using advanced surveillance and diagnostic methods.